 |
ABOUT US > COMPANY OVERVIEW |
Founded in 2003, Pharmaseed Bioservices is a GLP-certified boutique contract research organization (CRO) providing pre-clinical and consulting services for medical device, biotechnology and pharmaceutical companies. We also provide pre-formulation services for small and medium-size start-ups as well as idea and feasibility companies.
Along with our core clinical research CRO operations, we focus on niche areas, such as servicing companies developing therapies based on stem cell technologies.
We conduct most of our in vivo studies in a state-of-the-art lab space and animal facility based in Nes Ziona, Israel. The site is equipped for the acute and chronic evaluation of medical devices, pharmaceuticals and biotech R&D.
We offer a virtual lab data system, the first of its kind in the world. The system includes a state-of-the-art rodent facility and a network of complementary service providers. The network is a virtual CRO that gives clients access to emerging scientific fields and a laboratory with 24/7 data accessibility.
Pharmaseed’s range of skills is extensive, facilitating the kind of pharmaceutical and biopharmaceutical product development that requires the integration of many areas of expertise. The company specializes in both discovery and trial services using modern laboratory and animal facilities for the acute and chronic evaluation of bio-pharma and medical devices. Turnkey R&D service models are also available. The company's major focus is on the central nervous system, oncology, stem cell research and metabolic disorders.
Pharmaseed's lean and experienced team forms an efficient organization whose global reach includes a network of sponsors from the U.S., Europe, Canada and Israel. This network has enabled Pharmaseed to establish JV programs with pharmaceutical companies and academia as well as a top-tier S.A.B./K.O.L. panel from multinational bio-pharma companies.
Pharmaseed provides venture capital funds, investment banks and other funding sources with an unbiased evaluation of clients’ compounds, biologics and devices.
All our services are priced at a competitive rate in comparison to European and U.S.-based companies.
|
|
|
 |
| Cost-Effective Solutions |
Our goal is to optimize resources without compromising development speed. Via a network of collaborators with external test facilities, Pharmaseed complements its unique portfolio of services with conventional (standard toxicology battery) services. In doing so, Pharmaseed provides extensive, cost-effective and time-saving solutions for the regulatory and technology needs of innovative life-science companies up to the stage of first-in-man clinical trials.
|
|
|
